326 related articles for article (PubMed ID: 19495994)
1. Lessons for fragment library design: analysis of output from multiple screening campaigns.
Chen IJ; Hubbard RE
J Comput Aided Mol Des; 2009 Aug; 23(8):603-20. PubMed ID: 19495994
[TBL] [Abstract][Full Text] [Related]
2. Design of compound libraries for fragment screening.
Blomberg N; Cosgrove DA; Kenny PW; Kolmodin K
J Comput Aided Mol Des; 2009 Aug; 23(8):513-25. PubMed ID: 19283339
[TBL] [Abstract][Full Text] [Related]
3. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
Barelier S; Krimm I
Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
[TBL] [Abstract][Full Text] [Related]
4. Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation.
Loving K; Salam NK; Sherman W
J Comput Aided Mol Des; 2009 Aug; 23(8):541-54. PubMed ID: 19421721
[TBL] [Abstract][Full Text] [Related]
5. Fragment Hits: What do They Look Like and How do They Bind?
Giordanetto F; Jin C; Willmore L; Feher M; Shaw DE
J Med Chem; 2019 Apr; 62(7):3381-3394. PubMed ID: 30875465
[TBL] [Abstract][Full Text] [Related]
6. Using fragment-based technologies to target protein-protein interactions.
Bower JF; Pannifer A
Curr Pharm Des; 2012; 18(30):4685-96. PubMed ID: 22650253
[TBL] [Abstract][Full Text] [Related]
7. General Theory of Fragment Linking in Molecular Design: Why Fragment Linking Rarely Succeeds and How to Improve Outcomes.
Yu HS; Modugula K; Ichihara O; Kramschuster K; Keng S; Abel R; Wang L
J Chem Theory Comput; 2021 Jan; 17(1):450-462. PubMed ID: 33372778
[TBL] [Abstract][Full Text] [Related]
8. Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide.
Kawatkar S; Wang H; Czerminski R; Joseph-McCarthy D
J Comput Aided Mol Des; 2009 Aug; 23(8):527-39. PubMed ID: 19495993
[TBL] [Abstract][Full Text] [Related]
9. Development and NMR validation of minimal pharmacophore hypotheses for the generation of fragment libraries enriched in heparanase inhibitors.
Gozalbes R; Mosulén S; Carbajo RJ; Pineda-Lucena A
J Comput Aided Mol Des; 2009 Aug; 23(8):555-69. PubMed ID: 19421720
[TBL] [Abstract][Full Text] [Related]
10. Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics.
Lau WF; Withka JM; Hepworth D; Magee TV; Du YJ; Bakken GA; Miller MD; Hendsch ZS; Thanabal V; Kolodziej SA; Xing L; Hu Q; Narasimhan LS; Love R; Charlton ME; Hughes S; van Hoorn WP; Mills JE
J Comput Aided Mol Des; 2011 Jul; 25(7):621-36. PubMed ID: 21604056
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of 2D Difference Intensity Analysis for Chemical Library Screening by Protein-Detected NMR Spectroscopy.
Egner JM; Jensen DR; Olp MD; Kennedy NW; Volkman BF; Peterson FC; Smith BC; Hill RB
Chembiochem; 2018 Mar; 19(5):448-458. PubMed ID: 29239081
[TBL] [Abstract][Full Text] [Related]
12. Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology.
Neumann L; Ritscher A; Müller G; Hafenbradl D
J Comput Aided Mol Des; 2009 Aug; 23(8):501-11. PubMed ID: 19533372
[TBL] [Abstract][Full Text] [Related]
13. Binding site druggability assessment in fragment-based drug design.
Zhou Y; Huang N
Methods Mol Biol; 2015; 1289():13-21. PubMed ID: 25709029
[TBL] [Abstract][Full Text] [Related]
14. Covalent fragment-based drug discovery for target tractability.
McCarthy WJ; van der Zouwen AJ; Bush JT; Rittinger K
Curr Opin Struct Biol; 2024 Jun; 86():102809. PubMed ID: 38554479
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
Larsson A; Jansson A; Åberg A; Nordlund P
Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
[TBL] [Abstract][Full Text] [Related]
16. Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery.
Williams G; Ferenczy GG; Ulander J; Keserű GM
Drug Discov Today; 2017 Apr; 22(4):681-689. PubMed ID: 27916639
[TBL] [Abstract][Full Text] [Related]
17. Binding-site assessment by virtual fragment screening.
Huang N; Jacobson MP
PLoS One; 2010 Apr; 5(4):e10109. PubMed ID: 20404926
[TBL] [Abstract][Full Text] [Related]
18. F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Wollenhaupt J; Metz A; Barthel T; Lima GMA; Heine A; Mueller U; Klebe G; Weiss MS
Structure; 2020 Jun; 28(6):694-706.e5. PubMed ID: 32413289
[TBL] [Abstract][Full Text] [Related]
19. Fragment-based drug design: computational & experimental state of the art.
Hoffer L; Renaud JP; Horvath D
Comb Chem High Throughput Screen; 2011 Jul; 14(6):500-20. PubMed ID: 21521152
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of fragment screening methods on the p38α kinase: new methods, new insights.
Pollack SJ; Beyer KS; Lock C; Müller I; Sheppard D; Lipkin M; Hardick D; Blurton P; Leonard PM; Hubbard PA; Todd D; Richardson CM; Ahrens T; Baader M; Hafenbradl DO; Hilyard K; Bürli RW
J Comput Aided Mol Des; 2011 Jul; 25(7):677-87. PubMed ID: 21732248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
